Viewing Study NCT06618651



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06618651
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-26

Brief Title: A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors
Sponsor: None
Organization: None

Study Overview

Official Title: Phase I Study of Safety Tolerability Pharmacokinetics and Efficacy of SHR-3821 Injection in Subjects With Advanced Solid Tumors
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is an open label multi-center multiple dose Phase I study to evaluate the safety tolerability pharmacokinetics and efficacy of SHR-3821 injection in subjects with advanced solid tumors
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None